Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$31.71 - $38.95 $4.24 Million - $5.21 Million
133,800 New
133,800 $5.17 Million
Q4 2022

Feb 13, 2023

BUY
$49.7 - $57.71 $10.5 Million - $12.2 Million
211,500 New
211,500 $10.8 Million
Q4 2021

Feb 14, 2022

BUY
$74.57 - $87.19 $1.62 Million - $1.89 Million
21,700 Added 113.02%
40,900 $3.51 Million
Q1 2020

May 13, 2020

SELL
$71.57 - $93.3 $1.02 Million - $1.32 Million
-14,200 Reduced 42.51%
19,200 $1.56 Million
Q4 2019

Feb 10, 2020

BUY
$76.7 - $88.45 $1.2 Million - $1.38 Million
15,600 Added 87.64%
33,400 $2.79 Million
Q3 2019

Nov 14, 2019

SELL
$81.4 - $89.78 $7.16 Million - $7.9 Million
-88,000 Reduced 83.18%
17,800 $1.56 Million
Q2 2019

Aug 14, 2019

BUY
$73.44 - $82.41 $6.7 Million - $7.52 Million
91,200 Added 624.66%
105,800 $8.67 Million
Q1 2019

May 15, 2019

SELL
$64.48 - $81.31 $3.69 Million - $4.66 Million
-57,300 Reduced 79.69%
14,600 $1.19 Million
Q4 2018

Feb 14, 2019

BUY
$61.45 - $77.8 $1.77 Million - $2.24 Million
28,800 Added 66.82%
71,900 $4.73 Million
Q3 2018

Nov 14, 2018

SELL
$70.71 - $77.75 $395,975 - $435,400
-5,600 Reduced 11.5%
43,100 $3.32 Million
Q2 2018

Aug 14, 2018

SELL
$63.43 - $75.41 $723,102 - $859,674
-11,400 Reduced 18.97%
48,700 $3.6 Million
Q1 2018

May 15, 2018

BUY
$62.56 - $72.26 $2.46 Million - $2.85 Million
39,400 Added 190.34%
60,100 $3.91 Million
Q4 2017

Feb 14, 2018

SELL
$61.45 - $66.05 $2.86 Million - $3.07 Million
-46,500 Reduced 69.2%
20,700 $1.34 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $4 Million - $4.34 Million
67,200
67,200 $4.22 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.